JMP Securities Upgrades Ocera Therapeutics (OCRX) to Market Outperform
Tweet
Share
E-mailGet Alerts OCRX Hot Sheet
Price: $1.79 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
JMP Securities upgraded Ocera Therapeutics (NASDAQ: OCRX) from to Market Outperform with a price target of $15.00.
For an analyst ratings summary and ratings history on Ocera Therapeutics click here. For more ratings news on Ocera Therapeutics click here.
Shares of Ocera Therapeutics closed at $7.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
- Argus Upgrades APA Corp. (APA) to Buy
- DA Davidson Upgrades Duolingo Inc. (DUOL) to Buy
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
